Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Certara Teams Up with LabLogic Systems to Speed Up Drug Discovery Analyses

Published: Tuesday, December 17, 2013
Last Updated: Monday, December 16, 2013
Bookmark and Share
Partnership to integrate Certara’s Phoenix WinNonlin PK/PD modelling and non-compartmental analysis product with LabLogic’s Debra LIMS

Certara, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, has partnered with LabLogic Systems to integrate Certara’s Phoenix WinNonlin pharmacokinetic (PK)/pharmacodynamic (PD) modelling and non-compartmental analysis product with LabLogic’s Debra Laboratory Information Management System (LIMS).

Debra is used to manage data from absorption, distribution, metabolism, and excretion (ADME) and protein-binding studies. The resulting solution, allows customers who are using Debra 6 as their LIMS for drug metabolism studies, to push their data directly into Phoenix WinNonlin.

“This integration will allow the two systems to communicate directly, thus removing the need to export data from Debra,” said Dr Daniel Weiner, senior vice president and general manager at Certara. “It will increase system usability and should also provide quality control benefits.”

Debra can manage mass balance, tissue distribution, and PK results from ADME studies. With the addition of LabLogic’s Protein Binding module, Debra can also perform a comprehensive series of protein-binding assays.

Phoenix WinNonlin provides robust, intuitive modelling tools that allow researchers to visualize and analyze their PK and PK/PD data easily. It also enables them to collect all their results, including plots, tables and workflows, in a single project file. This convenient data management approach encourages results sharing and collaboration between team members.

“We developed this integration for Debra and Phoenix WinNonlin, two industry standard drug discovery software products, in direct response to customer requests,” said Huw Loaring, systems director at LabLogic. “We are always looking for ways to help our pharmaceutical customers to streamline their drug discovery process.”

LabLogic is managing customer requests for this product integration.

Certara is dedicated to improving human health by delivering a broad spectrum of software products and consulting services, spanning molecular discovery to clinical development, with special focus on supporting translational approaches to drug development.

LabLogic Systems is a premier instrument and software provider supporting PET/nuclear medicine facilities, pharmaceutical companies, agrochemical research, universities and contract research organizations for over 30 years.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

QPS Implements LabLogic's DEBRA LIMS
Fully validated LIMS now in use in QPS radiolabeled metabolism studies.
Tuesday, September 10, 2013
LabLogic Systems Acquires Southern Scientific
Southern Scientific manufactures and supplies radiation measurement, detection and analytical systems for the nuclear industry, hospitals and research.
Friday, September 09, 2011
LabLogic Strengthens Distributor Network
Professionals in Spain, the Czech Republic and Singapore now have local access to software and instrumentation from LabLogic Systems.
Friday, July 22, 2011
Radiochromatography Systems Assist Cancer Antibody Trials
The Cancer Sciences Division of Southampton University School of Medicine is using radio HPLC and radio TLC systems from LabLogic in the development and quality control of radio-labelled antibody conjugates undergoing clinical trials for treating haematological malignancies.
Tuesday, November 30, 2010
Transatlantic CRO Adopts Common Radio-Labelled ADME Platform
A US/UK contract research laboratory is standardizing on Debra 5.7.8, the latest release of LabLogic’s drug metabolism LIMS.
Monday, August 09, 2010
Drug Metabolism LIMS in Demand for Clinical Studies
LabLogic Systems reports a rapid rise in the number of clinical studies being performed using its drug metabolism LIMS Debra.
Wednesday, June 24, 2009
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
Kitchen Utensils Can Spread Bacteria Between Foods
In a recent study researchers found that produce that contained bacteria would contaminate other produce items through the continued use of knives or graters—the bacteria would latch on to the utensils commonly found in consumers' homes and spread to the next item.
Exploring the Causes of Cancer
Queen's research to understand the regulation of a cell surface protein involved in cancer.
Safer, Faster Way To Remove Pollutants From Water
Using nanoparticles filled with enzymes proves more effective than current methods.
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Ancient Viral Molecules Essential for Human Development
Genetic material from ancient viral infections is critical to human development, according to researchers at the Stanford University School of Medicine.
Novel Tumor Treatment
In the first published results from a $386,000 National Cancer Institute grant awarded earlier this year, a paper by Scott Verbridge and Rafael Davalos has been published.
Speeding Up the Process of Making Vaccines
System uses a freeze-dry concept to develop "just-add-water" solution.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos